Cargando…
Engineering monoclonal antibody-based contraception and multipurpose prevention technologies(†)
Sexually transmitted infections are highly prevalent, and over 40% of pregnancies are unplanned. We are producing new antibody-based multipurpose prevention technology products to address these problems and fill an unmet need in female reproductive health. We used a Nicotiana platform to manufacture...
Autores principales: | Anderson, Deborah J, Politch, Joseph A, Cone, Richard A, Zeitlin, Larry, Lai, Samuel K, Santangelo, Philip J, Moench, Thomas R, Whaley, Kevin J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401387/ https://www.ncbi.nlm.nih.gov/pubmed/32607584 http://dx.doi.org/10.1093/biolre/ioaa096 |
Ejemplares similares
-
Towards a roadmap to advance non-hormonal contraceptive multipurpose prevention technologies: strategic insights from key stakeholders(†)
por: Hemmerling, Anke, et al.
Publicado: (2020) -
Development of multipurpose technologies products for pregnancy and STI prevention: update on polyphenylene carboxymethylene MPT gel development(†)
por: Weitzel, Mary, et al.
Publicado: (2020) -
The new contraceptive revolution: developing innovative products outside of industry(†,‡)
por: Callahan, Rebecca L, et al.
Publicado: (2020) -
Retinoic acid receptor antagonists for male contraception: current status(†)
por: Noman, Md Abdullah Al, et al.
Publicado: (2020) -
The postcoital test in the development of new vaginal contraceptives
por: Mauck, Christine K, et al.
Publicado: (2020)